These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 33792899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucagon's chronotropic action is calcium dependent.
    Chernow B, Zaloga GP, Malcolm D, Willey SC, Clapper M, Holaday JW.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):833-7. PubMed ID: 2885409
    [Abstract] [Full Text] [Related]

  • 9. Glyburide sensitizes perfused rat liver to insulin-induced suppression of glucose output.
    McGuinness OP, Green DR, Cherrington AD.
    Diabetes; 1987 Apr; 36(4):472-6. PubMed ID: 3102299
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pancreatic glucagon's effects on satiety and hepatic glucose production are independently affected by diet composition.
    Langhans W, Scharrer E, Geary N.
    Physiol Behav; 1986 Apr; 36(3):483-7. PubMed ID: 3703978
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pancreatic glucagon: possible implications of the hyperglycemic hormone in diabetes control.
    Gossain VV, Rovner DR.
    Postgrad Med; 1982 Jul; 72(1):87-8, 91-3, 96. PubMed ID: 7088751
    [Abstract] [Full Text] [Related]

  • 16. Food deprivation dissociates pancreatic glucagon's effects on satiety and hepatic glucose production at dark onset.
    Geary N, Farhoody N, Gersony A.
    Physiol Behav; 1987 Jul; 39(4):507-11. PubMed ID: 3575498
    [Abstract] [Full Text] [Related]

  • 17. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect.
    Geary N, Smith GP.
    Physiol Behav; 1983 Sep; 31(3):391-4. PubMed ID: 6635010
    [Abstract] [Full Text] [Related]

  • 18. Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 Diabetes.
    Kitamura T.
    Endocrinol Metab (Seoul); 2024 Feb; 39(1):33-39. PubMed ID: 38417825
    [Abstract] [Full Text] [Related]

  • 19. The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.
    Pedersen C, Kraft G, Edgerton DS, Scott M, Farmer B, Smith M, Laneve DC, Williams PE, Moore LM, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2020 May 01; 318(5):E779-E790. PubMed ID: 32208001
    [Abstract] [Full Text] [Related]

  • 20. Glucagon, satiety from feeding and liver/pancreatic interactions.
    Vanderweele DA, Macrum BL, Oetting RL.
    Brain Res Bull; 1986 Oct 01; 17(4):539-43. PubMed ID: 3779454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.